Tag: nanotechnology
-
Nanotech Multi-Drug Delivery Technique Devised for Cancer
10 December 2015. A pharmacy lab at Oregon State University developed a technique for combining three drugs into nanoscale particles that treat melanoma spreading to lymph nodes in lab animals. The team led by Oregon State pharmacy professor Adam Alani published its proof-of-concept findings last month in Journal of Controlled Release (paid subscription required). Alani’s…
-
Researchers Develop Eye Injury Test, Start Company
9 December 2015. A medical and engineering team at University of Illinois in Champaign designed a sensor providing a quick, portable test for the severity of eye injuries. The researchers led by bioengineering professor Dipanjan Pan and ophthalmologist Leanne Labriola at Carle Foundation Hospital affiliated with the university described the proof-of-concept device last month in the…
-
Chlamydia Vaccine Shown Working in Lab Tests
2 December 2015. An experimental vaccine to prevent chlamydia was shown in tests with lab mice to prevent pelvic inflammation and clear bacteria more than mice not receiving the vaccine. The vaccine, given through the nose, is made by NanoBio Corp., a biopharmaceutical company in Ann Arbor, Michigan. Chlamydia is a sexually transmitted disease that…
-
Implanted Sensor to Measure Blood Sugar in Development
1 December 2015. An engineering group at University of Texas in Arlington is developing a system for people with diabetes to measure their blood glucose levels without taking repeated blood drops throughout the day. The work in the lab of biomaterials professor Kyungsuk Yum is funded by a $100,00 grant from the Texas Medical Research Collaborative.…
-
Chip Device Removes Nanoparticles from Plasma
23 November 2015. A team from University of California in San Diego used a miniature electronic chip to quickly separate nanoparticles for delivering drugs from blood plasma. The process, with a technology developed in the engineering lab of Michael Heller at UC-San Diego and licensed to a spin-off company from the university, is described in…
-
Nanotech Sensors Devised for RNA Cancer Detection
17 November 2015. Biochemical and medical researchers developed a technique for sensitive detection of RNA in humans that in lab tests can distinguish between benign conditions and cancer. The team from the lab of chemistry professor Rajesh Sardar at Indiana University-Purdue University Indianapolis published its findings in this month’s issue of the journal ACS Nano.…
-
Platelets Engineered to Deliver, Transcribe RNA
5 November 2015. A biochemistry lab at University of British Columbia developed a technique for supercharging blood platelets with genetic material, enabling these cells to deliver therapies through the blood stream. The team led by biochemist and molecular biologist Christian Kastrup published its findings this week in the journal Angewandte Chemie International Edition (paid subscription required).…
-
Artificial Kidney Implant Gains $6 Million Funding
3 November 2015. A collaboration of engineering and medical researchers is developing an implantable artificial kidney to reduce the need for dialysis in people with kidney failure awaiting a transplant. The four-year project combining teams from University of California in San Francisco with Vanderbilt University in Nashville, is funded by a $6 million grant from…
-
Spin-Off to Provide Lower-Cost Molecular Imaging Technology
13 October 2015. A new enterprise based on research at Harvard University is offering a technology that allows ordinary microscopes to display high resolution images of single molecules. The company, Ultivue Inc., is founded by and licensing technologies from the lab of Peng Yin at Harvard’s Wyss Institute for Biologically Inspired Engineering. Yin and colleagues…
-
Harvard Spin-Off Commercializing Sepsis Treatment
9 October 2015. A new enterprise spun-off from Harvard University is developing a device for treating sepsis, a life-threatening infection often contracted in hospitals. The company, Opsonix Inc. in Boston, also raised $8 million in its first round of venture funding. Opsonix is licensing a technology for treating sepsis developed in Harvard’s Wyss Institute for…